跳转至内容
Merck
CN
  • Safety of Noncontrast Imaging-Guided Deep Brain Stimulation Electrode Placement in Parkinson Disease.

Safety of Noncontrast Imaging-Guided Deep Brain Stimulation Electrode Placement in Parkinson Disease.

World neurosurgery (2019-11-23)
Joacir Graciolli Cordeiro, Anthony Diaz, Jenna Kylene Davis, Daniel Garbin Di Luca, Ghulam Farooq, Corneliu C Luca, Jonathan Russell Jagid
摘要

Deep brain stimulation (DBS) is considered standard of care for the treatment of medically refractory Parkinson disease (PD). The placement of brain electrodes is performed using contrast imaging to enhance blood vessel identification during stereotactic planning. We present our experience with a series of patients implanted using noncontrast imaging. All cases of DBS surgery for PD performed between 2012 and 2018 with noncontrast imaging were retrospectively reviewed. Clinical features, postoperative imaging, and complications were analyzed. A total of 287 deep-seated electrodes were implanted in 152 patients. Leads were placed at the subthalamic nucleus and globus pallidus internus in 258 and 29 hemispheres, respectively. We identified 2 cases of intracranial hemorrhage (0.7%). DBS lead placement can be performed without the use of intravenous contrast with a postoperative intracranial hemorrhage rate comparable with other reported series.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
3,3′-二碘-L-甲腺原氨酸 (T2), 98% (CP)